1. Clinical Overview
Piperacillin and Tazobactam is a fixed-dose combination injectable antibacterial agent. Piperacillin is an extended-spectrum penicillin (ureidopenicillin) with activity against a wide range of Gram-positive and Gram-negative bacteria. Tazobactam is a beta-lactamase inhibitor (a penicillanic acid sulfone derivative) that protects piperacillin from degradation by many beta-lactamase enzymes, thereby extending its spectrum of activity to include many beta-lactamase-producing strains that are otherwise resistant. This combination is a cornerstone of empiric therapy for serious nosocomial infections in the Indian hospital setting.
| Onset | Duration | Bioavailability |
|---|---|---|
| Rapid, with peak serum concentrations achieved within 30 minutes after a 30-minute intravenous infusion. | The dosing interval is typically every 6 to 8 hours, guided by its half-life and the principle of time-dependent bacterial killing. | Not applicable for intravenous administration; considered 100% bioavailable. |
2. Mechanism of Action
Piperacillin binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, inhibiting the final transpeptidation step of peptidoglycan synthesis. This leads to the formation of defective cell walls and osmotically unstable cells, resulting in bacterial cell lysis and death. Tazobactam has very weak antibacterial activity itself but irreversibly binds to and inhibits a wide variety of beta-lactamases (including many plasmid-mediated and chromosomal enzymes), thereby protecting piperacillin from enzymatic hydrolysis and extending its spectrum.
3. Indications & Uses
- Intra-abdominal infections (e.g., peritonitis, appendicitis, cholecystitis)
- Nosocomial pneumonia (including ventilator-associated pneumonia)
- Complicated urinary tract infections (including pyelonephritis)
- Complicated skin and skin structure infections
- Septicemia
- Febrile neutropenia (empiric therapy)
4. Dosage & Administration
Adult Dosage: 3.375 g (piperacillin 3g + tazobactam 0.375g) IV every 6 hours OR 4.5 g (piperacillin 4g + tazobactam 0.5g) IV every 8 hours for most serious infections. For nosocomial pneumonia, febrile neutropenia, and other life-threatening infections: 4.5 g IV every 6 hours.
Administration: For IV use only. Reconstitute powder with a suitable diluent (e.g., Sterile Water for Injection, 0.9% Sodium Chloride, 5% Dextrose). Further dilute in 50-150 mL of compatible IV fluid. Administer by intravenous infusion over 30 minutes. Do not mix with aminoglycosides in the same IV bag/syringe due to potential inactivation; administer separately.
5. Side Effects
Common side effects may include:
- Diarrhea (including Clostridioides difficile-associated diarrhea)
- Headache
- Insomnia
- Nausea/Vomiting
- Constipation
- Rash/Pruritus
- Local reactions at injection site (phlebitis, pain)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Probenecid | Inhibits renal tubular secretion of piperacillin, increasing and prolonging serum concentrations of both piperacillin and tazobactam. | Moderate |
| Aminoglycosides (e.g., Gentamicin, Amikacin) | Potential for physical-chemical inactivation if mixed in the same IV solution. Pharmacodynamic synergy against some organisms. | Moderate |
| Methotrexate | Piperacillin may reduce renal clearance of methotrexate, leading to increased methotrexate levels and toxicity. | Major |
| Oral Anticoagulants (Warfarin) | May potentiate anticoagulant effect and increase risk of bleeding due to effects on platelet function and vitamin K metabolism. | Major |
| Vecuronium | May prolong neuromuscular blockade. | Moderate |
| Oral Contraceptives | Potential reduction in efficacy due to altered enterohepatic circulation; advise use of alternative non-hormonal contraception. | Moderate |
7. Patient Counselling
- Complete the full prescribed course of therapy, even if you feel better.
- Inform all your healthcare providers (doctors, dentists) that you are on this medication.
- Do not skip any doses.
- Report any signs of new infection (e.g., oral thrush, vaginal yeast infection).
8. Toxicology & Storage
Overdose: Neurological manifestations are most prominent, including convulsions, encephalopathy, myoclonus, and neuromuscular excitability. Nausea, vomiting, and electrolyte disturbances may also occur.
Storage: Store unopened vials/powder at controlled room temperature (not exceeding 25°C), protected from light and moisture. After reconstitution and dilution, stability varies with diluent. Generally, solutions in 0.9% Sodium Chloride or 5% Dextrose are stable for up to 24 hours at room temperature or 7 days if refrigerated (2-8°C). Always refer to the specific manufacturer's instructions. Do not freeze.